Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02966548
Recruitment Status : Active, not recruiting
First Posted : November 17, 2016
Last Update Posted : December 6, 2021
Ono Pharmaceutical Co. Ltd
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 8, 2022
Estimated Study Completion Date : September 9, 2022